Labcorp Announces CFO Julia Wang to Present at UBS Global Healthcare Conference
LABCORP HOLDINGS INC.
Subscribe to track LH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
š¢ Labcorp Holdings Inc. ($LH) Files Form 8-K
⢠Event: Item 7.01 Regulation FD Disclosure ⢠Summary: Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026, at 8:45 a.m. ET. ⢠Webcast: Live audio webcast available on ir.labcorp.com and archived for 180 days. ⢠Filing Date: November 4, 2026
Comprehensive Analysis
Summary of Event
On November 4, 2026, Labcorp Holdings Inc. filed a Current Report on Form 8-K under Item 7.01 (Regulation FD Disclosure).
Key Highlights
- Presentation Announcement: Chief Financial Officer Julia Wang is scheduled to participate in a fireside chat at the UBS Global Healthcare Conference on November 10, 2026, at 8:45 a.m. ET.
- Webcast Details: A live audio webcast will be available via Labcorp's Investor Relations website (
ir.labcorp.com) and archived for 180 days following the event. - Exhibit 99.1: The accompanying press release was furnished as an exhibit to the filing.
Market Impact & Significance
This is a standard informational filing regarding executive participation at an industry investor conference. It does not disclose any financial revisions or material corporate transactions, representing Low immediate market-moving significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
